Effectiveness and acceptability of a smart inhaler asthma self-management program. Will younger clients can use this technology independently, or will assistance from parents or guardians be needed?

 

The younger clients will need assistance from parents or guardians when using this technology to get optimum results. Although most devices guide asthma patients on the appropriate use of the inhalers, it is challenging for younger clients to adhere to the provided instructions without being assisted (van de Hei et al., 2019).Effectiveness and acceptability of a smart inhaler asthma self-management program. For instance, the device informs the user if they have used the inhaler correctly to get adequate medicine into the lungs, thus minimizing possible side effects. However, young clients do not understand the provided details about using the inhaler if not assisted, thus increasing the risk of side effects. Therefore, parents or guardians should help younger patients get benefits associated with smart inhalers, such as having better control over asthma, thus improving the quality of life.Effectiveness and acceptability of a smart inhaler asthma self-management program.

Will this technology follow the child throughout the teenage years, or will a change be needed as the client ages and develops? Give an example

Some changes will be required as the client ages and develop due to changes in care needs. The care needs of pediatric patients with asthma, such as dosage and frequency of taking the medication, changes with age, thereby necessitating some adjustment in the smart inhalers. For example, a Nebulizer solution: 0.25 mg per mL administered every 6 hours is required to manage asthma in children aged five years. On the other hand, 0.5 mg per mL administered every 4 hours is recommended for managing this chronic condition in adolescents (Tesse et al., 2018).Effectiveness and acceptability of a smart inhaler asthma self-management program.

Overall, smart inhalers are effective in the management of asthma in a pediatric patient. This technology sends reminders to patents to infirm them when they are supposed to take their medication. Additionally, it facilitates the sharing of data between the patient and a care provider, thus enhancing the management asthma in this patient population. However, this device’s efficacy in managing asthma among school-age children depends on how the users and their families adhere to the provided instructions about its usage.

Order this paper